Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Evaluating the Efficacy and Effectiveness of Long Acting Injectables Versus Oral Antipsychotics in the Treatment of Schizophrenia


Date: Jun 19, 2020 01:30 PM - 02:30 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Aug 14, 2020 11:55 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

 

Objectives

  • Describe the clinical manifestations of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM5)
  • Explain the pharmacological treatment approach for schizophrenia and identify the differences in tolerability of typical and atypical antipsychotic
  • Identify the clinical factors and patient preferences that influence the prescribing of different antipsychotic formulations
  • Interpret the clinical trial outcomes of studies regarding the use of long acting injectables versus oral antipsychotics in schizophrenia therapy

Speaker(s)/Author(s)

Jessica Pinchinat, PharmD, RPh

Activity Number

0010-0000-20-019-L01-P
Date: 06/19/20
Time: 01:30 PM - 02:30 PM

CE Hours

1.00